These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8871002)

  • 21. HDR intraluminal brachytherapy in the treatment of malignant bronchial obstructions.
    Petera J; Neumanová R; Vrba M; Coupek P; Salajka F; Hrazdírová A; Kucera M; Snízek T; Kolman P; Hanák V
    Neoplasma; 2000; 47(1):56-9. PubMed ID: 10870688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer.
    Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M
    Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Place of iridium 192 implantation in irradiation of T1-T2 squamous cell carcinoma of the velopharyngeal arch].
    Mazeron JJ; Belkacemi Y; Simon JM; Le Péchoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynègre R; Le Bourgeois JP; Pierquin B
    Bull Cancer Radiother; 1996; 83(1):47-53. PubMed ID: 8679281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma.
    Le QT; Fu KK; Kroll S; Ryu JK; Quivey JM; Meyler TS; Krieg RM; Phillips TL
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):115-26. PubMed ID: 9300746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of failure and survival in endobronchial laser resection. A matched pair study.
    Macha HN; Becker KO; Kemmer HP
    Chest; 1994 Jun; 105(6):1668-72. PubMed ID: 7515777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraluminal irradiation in the treatment of malignant airway obstruction.
    Kohek PH; Pakisch B; Glanzer H
    Eur J Surg Oncol; 1994 Dec; 20(6):674-80. PubMed ID: 7995420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endobronchial brachytherapy in the treatment of malignant lung tumours.
    Escobar-Sacristán JA; Granda-Orive JI; Gutiérrez Jiménez T; Delgado JM; Rodero Baños A; Saez Valls R
    Eur Respir J; 2004 Sep; 24(3):348-52. PubMed ID: 15358689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Radiotherapy of localized inoperable bronchial squamous cell carcinoma (author's transl)].
    Laval P; Kleisbauer JP; Rathelot P; Poirier R; Bettendorf A
    Rev Fr Mal Respir; 1979 Dec; 7(7):747-50. PubMed ID: 555016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of roentogenographically occult endobronchial carcinoma with external beam radiotherapy and intraluminal low dose rate brachytherapy.
    Saito M; Yokoyama A; Kurita Y; Uematsu T; Miyao H; Fujimori K
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):1029-35. PubMed ID: 8600085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endobronchial brachytherapy and external-beam radiotherapy in patients with endobronchial obstruction and extrabronchial extension.
    Gejerman G; Mullokandov EA; Bagiella E; Blaivas A; Beitler JJ
    Brachytherapy; 2002; 1(4):204-10. PubMed ID: 15062168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination external beam radiotherapy and high-dose-rate intracavitary brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule.
    Toita T; Kakinohana Y; Ogawa K; Adachi G; Moromizato H; Nagai Y; Maehama T; Sakumoto K; Kanazawa K; Murayama S
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1344-53. PubMed ID: 12873679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Place of Iridium 192 implantation in definitive irradiation of faucial arch squamous cell carcinomas.
    Mazeron JJ; Belkacemi Y; Simon JM; Le Pechoux C; Martin M; Haddad E; Piedbois P; Calitchi E; Strunski W; Peynegre R
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):251-7. PubMed ID: 8407398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma.
    Olivier KR; Schild SE; Morris CG; Brown PD; Markovic SN
    Cancer; 2007 Oct; 110(8):1791-5. PubMed ID: 17721993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraluminal high-dose-rate brachytherapy for palliation of dysphagia in cancer of the esophagus: initial experience at a single UK center.
    Bhatt L; Tirmazy S; Sothi S
    Dis Esophagus; 2013 Jan; 26(1):57-60. PubMed ID: 22404484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
    Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
    J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIB-IVA squamous cell carcinoma of the cervix.
    Chaney AW; Eifel PJ; Logsdon MD; Morris M; Wharton JT
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):113-8. PubMed ID: 10477014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study.
    Pérol M; Caliandro R; Pommier P; Malet C; Montbarbon X; Carrie C; Ardiet JM
    Chest; 1997 May; 111(5):1417-23. PubMed ID: 9149603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-treatment of nasopharyngeal carcinoma in 53 patients.
    Pryzant RM; Wendt CD; Delclos L; Peters LJ
    Int J Radiat Oncol Biol Phys; 1992; 22(5):941-7. PubMed ID: 1555986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.